Acarix AB Stock Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- SEK | - |
|
06-11 | Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study | CI |
05-27 | Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 | CI |
Sales 2024 * | 54.3M 5.18M 7.08M | Sales 2025 * | 177M 16.83M 23.04M | Capitalization | 328M 31.26M 42.78M |
---|---|---|---|---|---|
Net income 2024 * | -54M -5.15M -7.04M | Net income 2025 * | 2M 191K 261K | EV / Sales 2024 * | 5.97 x |
Net cash position 2024 * | 4M 381K 522K | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.86 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.96% |
Latest transcript on Acarix AB
Managers | Title | Age | Since |
---|---|---|---|
Founder | 60 | 06-12-31 | |
Director of Finance/CFO | 60 | 15-12-31 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 51 | 21-05-10 | |
Director/Board Member | 59 | 19-12-31 |
1st Jan change | Capi. | |
---|---|---|
-34.27% | 14.7B | |
-52.73% | 2.33B | |
+24.29% | 1.96B | |
-8.30% | 1.52B | |
+21.24% | 1.24B | |
-21.39% | 904M | |
-34.32% | 750M | |
+1.33% | 784M | |
-28.73% | 597M |